Equibles does not estimate personal net worth.
Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRPT alertsDoug Ingram is recorded as CEO at Sarepta Therapeutics, Inc. (SRPT). Doug Ingram has spoken on 18 earnings calls and 2 other investor events across 1 company, most recently for Sarepta Therapeutics, Inc. on June 8, 2026. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Douglas Ingram (CEO and Board Member), Michael Severino, M.D. (CEO and Board Member), M. Kathleen Behrens (Chairman) and 7 others.
“You can ask these folks if I've been winding down recently. I think they're surprised my intensity level's been going up. You know, right now we're not transitioning anything.”
“Good afternoon, everyone, and thank you for joining us throughout the Therapeutics First Quarter 2026 Financial Results Conference. call. We entered 2026 with a clear set of priorities.”
“Good afternoon, and thank you for joining us throughout the Therapeutics fourth quarter and full year 2025 financial results conference call. As you will hear today, we've entered 2026 on a strong footing.”
“You know, a Duchenne expert once said to me, and I quote, By definition, Duchenne boys do not ride bicycles. Well, this boy here, Max, riding this bicycle in this picture, has Duchenne.”
“We have much to discuss this evening, but let's begin by reviewing the completion of our confirmatory study for our two ultra-rare disease TMOs, Lyondis and Amondis, before coming back to our quarterly update.”
Biotechnology · Healthcare
CEO
